Overall, this article not only advances understanding of modern clinical trial design but also provides valuable insight into the competencies required to contribute effectively in precision medicine. It has reinforced my understanding of how translational research connects to clinical implementation and highlighted key areas for further skill development as I transition toward a career in clinical and translational research.

Fountzilas et al. provide a comprehensive synthesis of the evolving landscape of clinical trial design in precision oncology, effectively framing the transition from histology-driven to biomarker-informed therapeutic strategies. A key strength lies in the structured overview of innovative designs particularly basket, umbrella, and platform trials, and their positioning within the limitations of conventional phase I-III frameworks. The inclusion of representative trials enhances translational relevance and reinforces the clinical momentum of biomarker-matched therapies.